Skip to main content

MoneyWorks4Me

Ind-Swift Laboratories informs about disclosure

28 Mar 2024 Evaluate

Ind-Swift Laboratories has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for EC Special Situation Fund & Others.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..